Valeda LDS, the treatment for patients suffering from Dry Age-Related Macular Degeneration
Managing Dry Macular Degeneration (AMD)
Age-Related Macular Degeneration is a gradual loss of vision that progresses with age. It normally affects central vision, particularly contrast sensitivity, dark adaptation, colour vision and depth perception – changes that influence performance and experience of day-to-day tasks and hobbies such as reading, driving, watching TV, painting etc. Early stages of the disease tend to primarily affect the rods, the receptors responsible for night vision. These are not usually assessed in a routine sight test. Due to the degenerative and progressive nature of the disease process and the incredible complexity of the human visual system and brain, dry AMD is only normally detected when the disease is already significantly advanced – i.e. when it has already started to affect the cones, the receptors responsible for high contrast, central and colour vision. We are constantly surrounded by artificial lighting, headlights, streetlamps etc., hence are completely unaware of changes in our night vision until there has been a significant and often life changing deterioration in our vision.
Valeda Light Delivery System (LDS) is the world’s first and only treatment approved using Photobiomodulation Therapy (PBMT) to treat dry age-related macular degeneration. The aim of the treatment is to slow down the progression of the disease and if caught early enough to even improve your visual performance in day-to-day activities – so you can enjoy improved vision for longer, as well as enhanced quality of life. Treatment with Valeda improves visual acuity and contrast sensitivity and reduces central drusen volume. Valeda uses light-emitting diodes (LEDs) to stimulate cellular function, leading to improved energy production within the mitochondria. Treatments are delivered in a series of 9 sessions per eye over a three-week period. Each treatment session takes approximately 5 minutes per each eye. Lumithera recommends to undertake the treatment every four months on an ongoing basis.
Assessment and treatment protocol:
1 – Initial assessment – The initial appointment allows us to investigate your eyes current functional and structural status and enables a baseline to be established for both function and structure allowing both you and us to monitor the effects of the treatment over time.
Please allow up to 2.5 hours for the initial appointment. You are able to have your first treatment immediately following your assessment. Unless you have a previously un-diagnosed condition that precludes treatment or have wet macula degeneration you can normally commence the first treatment on the same day.
Appointment fees for the initial assessment are £250, payable at the time of booking to secure your appointment. Please bring your up-to-date spectacles, prescription and any relevant ocular medical history.
2 – Treatment sessions – After you have completed the assessment you will have 9 treatments administered. The first session can be undertaken immediately after your baseline assessment. Ideally, the treatments are scheduled every-other-day or at least 3 treatments per week for 3 weeks in a row. The practice is open seven days per week to allow this. Each treatment session takes approx. 10 mins.
3 – Post-treatment assessment is undertaken ideally six to eight weeks after your last treatment session . The post-treatment assessment can take up to 2 hours.
4 – Data analysis -Following the post treatment assessment your results will be analysed by the optometrist and a copy of the report will be emailed to you. Due to the complexity of the analysis please allow 4 to 6 weeks to receive your report.
We would be delighted to see you in our clinic, however we understand that travel and the time commitment is quite large so we have included the link to the Valeda locator so that you can easily find a centre closer to your location if necessary. https://eu.lumithera.com/contact-us/valeda-locator/
£1650 for 1 cycle of treatment for both eyes
£1450 for 1 cycle of treatment for one eye only
Special offer – Every time you schedule your Valeda treatment you will receive 5 complimentary sessions on the NovoThor Whole Body Light Pod. This is not part of the LumiThera treatment but is a whole body light pod that reduces inflammation and promotes healing in the whole body. There is increasing evidence that inflammation in the body also effects the eyes and brain the light pod may enhance the effects of the Valeda treatment.
Photobiomodulation (PBM) is the application of different wavelengths of light, most commonly red and near-infrared. PBM therapy improves metabolism within the mitochondria – organelles within cells that are responsible for energy production. So far, research has shown that PBM therapy attenuates degeneration in sick retina and optic nerve cells, accelerates wound healing, and improves recovery from ischemic injury.